Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02442726
Other study ID # H-2-2014-002
Secondary ID
Status Completed
Phase N/A
First received May 3, 2015
Last updated December 2, 2015
Start date May 2015
Est. completion date November 2015

Study information

Verified date December 2015
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: Ministry of HealthDenmark: Danish Health and Medicines Authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to measure reaction times and thermal detection thresholds to CO2 laser stimulation of the skin, before and after a first degree thermal injury, in the primary and secondary hyperalgesia area, in order to investigate whether different nerve-fiber classes are activated in the post-injury phase. The study results are expected to uncover existence of a peripheral inflammatory input contributing to secondary hyperalgesia.


Description:

BACKGROUND The conduction speed of peripheral nerve fibers depends on the nerve diameter. The conduction velocity of large myelinated fibers are 50 - 120 m/s, while for the smaller myelinated A-delta- and unmyelinated C-fibers, they are in the range of 5-10 m/s, and 0.5-1 m/s, respectively. Applying short laser pulses with a high energy density and synchronization, simple reaction times can be used to determine the type of fiber class that has been activated. Research from the group of Plaghki and colleagues has shown that when stimulating surface areas are between 15 and 50 sq.mm at a supra-threshold intensity for activating A-delta-fibers, a typical bimodal response pattern is observed with a first peak centered around 400 ms and a second around 850 ms. Whereas the early peak is due to activation of A-delta-fibers, the second peak is caused by C-fiber activation.

HYPOTHESIS Following a mild thermal skin injury (47ÂșC, 420 s, 9.0 or 12.5 sq.cm area) the injured area is associated with erythema and an increased sensitivity, i.e. pain is easily evoked by mechanical and thermal stimuli in the primary hyperalgesia area. In normal skin surrounding the injury mechanical and thermal allodynia and hyperalgesia, are present. Innocuous stimuli in this secondary hyperalgesia area may elicit pain. This is believed to be a central process suggested by pioneering research in the 1980s and 1990s. The term for this phenomenon is heterosynaptic central facilitation meaning that innocuous stimuli may activate normally high-threshold nociceptive dorsal horn neurons leading to allodynia. This conversion of an innocuous stimulus in normal skin just outside of the injury, to a pain generating stimulus, is the result of a change in the sensory processing within the CNS. This processing is probably regulated by spino-bulbo-spinal loops including the rostral ventro-medial medulla (RVM) and locus coeruleus (LC).

The study hypotheses are, first, that the reaction times at the thermal injury site (i.e. primary hyperalgesia area) are changed compared to the pre-injury level. Second, that the sensory changes in the secondary hyperalgesia area, following a thermal injury, are not exclusively centrally mediated, but that also changes in peripheral afferents, e.g. A-delta-fibers (AMH type I) are demonstrable by assessments of reaction times to CO2 laser pulses.

A well-known alternative to laser stimulation is the use of a contact thermode with a much larger stimulation area, i.e. 2.5 to 16 sq.cm. The substantially larger area of the contact thermode, combined with a slower heating rate, compared to the laser stimulus (< 0.5 sq.cm, 10 ms), may induce pronounced spatial and temporal summation, interfering with accurate interpretation of sensory data. A recent method-comparison study in patients with postherpetic neuralgia, comparing assessments obtained by a contact thermode (9 sq.cm) and by laser stimuli (< 0.25 sq.mm), indicates that the laser method is more sensitive and specific in detecting thermal sensory abnormalities. Since the laser stimulus gives a steeper slope of heating profile and a more synchronized activation of warmth- and heat-sensitive small fibers, i.e. C- and A-delta-fibers, in the skin laser stimulation is the preferred method in the present study.

CLINICAL IMPLICATIONS The propensity for developing secondary hyperalgesia may reflect a predisposition for developing persistent postsurgical pain. It has been estimated that 2-10% of patients undergoing otherwise uncomplicated surgical procedures will suffer from persistent postsurgical pain. Investigating the pathophysiological mechanisms behind secondary hyperalgesia may therefore increase our understanding of the transition to chronic pain and thereby improve our management strategies for this large patient group.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date November 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- healthy right-handed males

- non-smokers (due to fluctuating skin temperatures in smokers)

- normal thermal perception (warmth detection threshold [WDT], cool detection threshold [CDT] and heat pain threshold [HPT])

- familiarized with the thermal injury and quantitative sensory testing

- understands written and verbal study information in Danish

- understands written and verbal study information in English

Exclusion Criteria:

- lesions on the lower leg

- unable to cooperate with the sensory testing

- suspected neurological disease

- hereditary predisposition to peripheral neurological disease

- inability to develop secondary hyperalgesia area (non-responder)14

- "small-area" responder (secondary hyperalgesia area < 36 cm2)

- participated in pharmacological trials during the preceding 4 weeks

- participated in a thermal-injury trial during the preceding 8 weeks

- intake of any medication during the preceding 48 hours

- intake of prescription drugs during the preceding 7 days

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Device:
CO2-Laser stimulation (Laser Stimulation Device, SIFEC)
Laser stimuli are evenly applied in 15 spots (each 6 mm in diameter) in the primary hyperalgesic zone (application zone of the contact thermode) and in the secondary hyperalgesic zone (1 cm outside the application zone of the contact thermode).

Locations

Country Name City State
Denmark BRAINLab, Department of Neuroscience and Pharmacology, Panum Institute Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
University of Copenhagen

Country where clinical trial is conducted

Denmark, 

References & Publications (16)

Arendt-Nielsen L, Chen AC. Lasers and other thermal stimulators for activation of skin nociceptors in humans. Neurophysiol Clin. 2003 Dec;33(6):259-68. Review. — View Citation

Cook AJ, Woolf CJ, Wall PD. Prolonged C-fibre mediated facilitation of the flexion reflex in the rat is not due to changes in afferent terminal or motoneurone excitability. Neurosci Lett. 1986 Sep 25;70(1):91-6. — View Citation

Franz M, Spohn D, Ritter A, Rolke R, Miltner WH, Weiss T. Laser heat stimulation of tiny skin areas adds valuable information to quantitative sensory testing in postherpetic neuralgia. Pain. 2012 Aug;153(8):1687-94. doi: 10.1016/j.pain.2012.04.029. Epub 2012 May 31. — View Citation

Johansen A, Schirmer H, Stubhaug A, Nielsen CS. Persistent post-surgical pain and experimental pain sensitivity in the Tromsø study: comorbid pain matters. Pain. 2014 Feb;155(2):341-8. doi: 10.1016/j.pain.2013.10.013. Epub 2013 Oct 18. — View Citation

Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. Review. — View Citation

LaMotte RH, Lundberg LE, Torebjörk HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol. 1992 Mar;448:749-64. — View Citation

Martinez V, Ben Ammar S, Judet T, Bouhassira D, Chauvin M, Fletcher D. Risk factors predictive of chronic postsurgical neuropathic pain: the value of the iliac crest bone harvest model. Pain. 2012 Jul;153(7):1478-83. doi: 10.1016/j.pain.2012.04.004. Epub 2012 May 2. — View Citation

Naert AL, Kehlet H, Kupers R. Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain. 2008 Aug 15;138(1):163-71. doi: 10.1016/j.pain.2007.11.018. Epub 2008 Jan 22. — View Citation

Pedersen JL, Kehlet H. Hyperalgesia in a human model of acute inflammatory pain: a methodological study. Pain. 1998 Feb;74(2-3):139-51. — View Citation

Pedersen JL, Kehlet H. Secondary hyperalgesia to heat stimuli after burn injury in man. Pain. 1998 Jun;76(3):377-84. — View Citation

Plaghki L, Mouraux A. How do we selectively activate skin nociceptors with a high power infrared laser? Physiology and biophysics of laser stimulation. Neurophysiol Clin. 2003 Dec;33(6):269-77. Review. — View Citation

Ravn P, Frederiksen R, Skovsen AP, Christrup LL, Werner MU. Prediction of pain sensitivity in healthy volunteers. J Pain Res. 2012;5:313-26. doi: 10.2147/JPR.S33925. Epub 2012 Aug 29. — View Citation

Torebjörk HE, LaMotte RH, Robinson CJ. Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol. 1984 Feb;51(2):325-39. — View Citation

Torebjörk HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 1992 Mar;448:765-80. — View Citation

Werner MU, Petersen KL, Rowbotham MC, Dahl JB. Healthy volunteers can be phenotyped using cutaneous sensitization pain models. PLoS One. 2013 May 9;8(5):e62733. doi: 10.1371/journal.pone.0062733. Print 2013. — View Citation

Woolf CJ, Wall PD. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci. 1986 May;6(5):1433-42. — View Citation

* Note: There are 16 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in distribution of reaction times assessed by laser stimuli in the thermal injury area (the primary hyperalgesia area) comparing post-injury values with pre-injury, baseline values. Assessments are performed at Baseline, 1 h post-thermal injury and 24 h post-thermal injury. Changes compared to Baseline are analyzed. 24 hours No
Primary Changes in distribution of reaction times assessed by laser stimuli in the secondary hyperalgesia area comparing post-injury values with pre-injury, baseline values. Assessments are performed at Baseline, 1 h post-thermal injury and 24 h post-thermal injury. Changes compared to Baseline are analyzed. 24 hours No
Secondary Changes in thermal pain thresholds assessed by laser stimuli in the thermal injury area (the primary hyperalgesia area) comparing post-injury values with pre-injury, baseline values. Assessments are performed at Baseline, 1 h post-thermal injury and 24 h post-thermal injury. Changes compared to Baseline are analyzed. 24 hours No
Secondary Changes in thermal pain thresholds assessed by laser stimuli in the secondary hyperalgesia area comparing post-injury values with pre-injury, baseline values. Assessments are performed at Baseline, 1 h post-thermal injury and 24 h post-thermal injury. Changes compared to Baseline are analyzed. 24 hours No
Secondary Thermal detection thresholds assessed by laser stimuli in the thermal injury area (the primary hyperalgesia area) comparing post-injury values with pre-injury, baseline values. Baseline, 1 h post-thermal injury; 24 h post-thermal injury No
Secondary Changes in thermal detection thresholds assessed by laser stimuli in the secondary hyperalgesia area comparing post-injury values with pre-injury, baseline values. Assessments are performed at Baseline, 1 h post-thermal injury and 24 h post-thermal injury. Changes compared to Baseline are analyzed. 24 hours No
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1